DTGM Fusion Protein

· Wake Forest University Health Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTGM Fusion Protein, covering 2017-01-19 to 2017-01-19. Get the full timeline:

Most recent: Clinical Trial Update: DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]